Closed
Transformative Healthcare Instrument 2026
Grant
About
The Transformative Healthcare Instrument 2026 offers European healthcare startups funding between €300,000 and €500,000 to advance product development and commercialisation strategies while addressing unmet clinical needs, with specific eligibility criteria focused on company size and investment history.
Benefits
- 💰FundingRequest between €300,000 and €500,000 in funding; maximum 50% of total project costs covered
- 📈Commercialisation supportStrengthen commercialisation strategies and prepare for fundraising
- 🧪Product developmentAdvance product development addressing unmet clinical needs
Eligibility Criteria
- Private companies
- Micro, Small and Medium-sized enterprises (SMEs)
- At least 4 full-time equivalent employees
- Minimum total equity investment of 2,000,000 EUR within the previous 36 months
- Specific Innovation Maturity Levels depending on industry focus
Participation Commitments
- Secure remaining 50% co-funding from other sources.
- Participate in scheduled sessions for guidance.
Target Sector
Biotech, Medtech, Digital Health, AI, Biomarkers, Diagnostics
Target Location
Europe
Want to discover more opportunities like this?
Join StartupLinkX for free and get matched with relevant funding, competitions, grants, and more.
Found an issue with this listing?
EIT Health